Controlled Substances Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028

  • Published : Mar-2019
  • Tables : 56
  • Figures : 196
  • Category : Healthcare
  • No. of Pages : 170
  • Report Code : FACT2032MR
  • Format : ppt
controlled substances market snapshot

Controlled Substances Market – Key Insights 

  • The controlled substances market registered a CAGR of over 3% during the period, 2013 to 2017. Sales of controlled substances are expected to remain underpinned by efforts of mature markets in reducing costs to create an affordable landscape for end-users.
  • The controlled substances market was valued in excess of US$ 42,000 Mn in 2018, and is projected to record a modest expansion at 4% CAGR through 2028.
  • North America has traditionally been the most lucrative market for controlled substances, with sales estimated to record a Y-o-Y of 3.5% in 2019 over 2018. This can be attributes in part to legalization of various forms of marijuana in the US, along with the recent approval of recreational marijuana sales in Canada.
  • Latin America is expected to exhibit the fastest growth in the controlled substances market through 2028. Uruguay, and Colombia continue to gain significance as an attractive market for medical marijuana in Latin America, in light of their emerging stature. 
controlled substances market assessment for stimulants and opoids

For more insights into the controlled substances market, get the sample of the report. 

What are Key Growth Influencers of the Controlled Substances Market? 

  • Adoption of controlled substances for management & treatment of a wide range of medical conditions, including obesity, diarrhea suppression, and refractory exogenous obesity. This has resulted in an expanding patient pool in the marketplace, in turn creating lucrative growth opportunities.
  • There has been a notable rise in advertisement campaigns apropos of public awareness on use of controlled substances, with regard to their licensing, registration, use, and storage, which in turn is upholding sales.
  • Growing preference for medical marijuana over prescription drugs for managing headaches, depression, back problems, and pain, despite criminalization, alludes current public health framework that deems cannabis abstinence becoming obsolete.
  • The WHO has been taking immense efforts for improving the access to controlled substances, by collaborating with producers and suppliers across countries with potential growth. These efforts are directed toward capacity building of dispensers & prescribers, along with the development of balanced legislation and policies.
  • Global leaders in the controlled substances market are focusing on expansion of their product pipeline of novel controlled substance-based drugs. For instance, nearly 15 abuse deterrent formula opioids are in late stage clinical trials, which are focused on continued investment in ADFs. 

For more intelligence on growth influencers of the controlled substances market, get the sample of the report. 

Which Factors are Arresting Growth of the Controlled Substances Market? 

  • Suspicious order monitoring (SOM) requirement of the Drug Enforcement Agency (DEA) mandates registered distributors of opioids to inculcate systems that signify suspicious orders of the controlled substances.
  • High prevalence of illicit controlled substances is a significant challenge that has resulted in a raw material shortage for legitimate controlled substance manufacturers. 

Controlled Substances Market – Competition Landscape 

  • GW Pharmaceuticals has announced its plan of epidiolex (CBD or cannabidiol) development program in 2018, to combat infantile spasms, which according to the company is the fourth largest target indication for its program of epidiolex orphan pediatric epilepsy development.
  • Molecular Science Corporation and Canopy Growth entered into a strategic collaboration in 2018, to pioneer standardized testing methods for analyzing and enhancing the efficacy of cannabis testing, its safety awareness and product knowledge.
  • Aphria Incorporation has signed an exclusive agreement with Colcanna SAS for extending its medical cannabis sales in Columbia. Aphria eyes to leverage the large distribution footprint of Colcanna SAS to market its MMJ products in Columbia.

Key players operating in the controlled substances market, as identified in the report, include CANNABIS SATIVA, INC., The Peace Naturals Project, Canopy Growth Corporation, GW PHARMACEUTICALS PLC, Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals, Inc., Mallinckrodt plc, SAFC/Cerilliant, Noramco, Inc., Johnson Matthey, Siegfried AG, AMRI, Cayman Chemical, Consort Medical, Patheon, and Cambrex. 

controlled substances market competition canvas

Get the summary of the report to get more information on the competition landscape of the controlled substances market.

Additional Insights

Electronic Prescribing of Controlled Substances – A Key Trend 

Electronic prescribing of controlled drugs, which emerged as a key trend in the past decade focusing on adoption and utility, has witnessed a paradigm shift toward quality- and optimization-based developments in the past few years. This has further led to an increased efficiency of processes associated with physicians, such as reduced follow-up times for detecting errors owing to time saved from procuring them electronically. Encouraging access to electronic health records for the same has further resulted in timely product validation and verification prior to procurement. As of 2018, nearly 22 states in the US have current or impending legislations for electronic prescribing of controlled substances. 

New Laws Implemented on Opioids 

The Opioid Reduction Act was implemented by the West Virginia Department of Health and Human Resources, setting limitations on the opioid prescriptions, and enabling patients to place directives in their medical files apropos of advanced treatment that involve opioid medications. Additionally, the legislation enables patients top opt out of treatment with opioids in advance, via filling the form of Voluntary Opioid Advanced Directive. This initiative to reduce the use of opioids, particularly for beginners, is a huge step taken toward turning the tap off in opioid crisis, while preventing new patients from getting addicted to these drugs.

Scope of the Report  

controlled substances market taxonomy

Research Methodology 

This report offers holistic insights on the controlled substances market, along with important numbers such as revenue comparison, Y-o-Y growth comparison, and market share comparison of key segmented identified in the controlled substances market. Key trend affecting the growth of the controlled substances market have also been analyzed in the report, along with their degree of impact intensity on the controlled substances market. 

Insights and analysis offered on the controlled substances market in this report are backed by a robust research methodology, which involves a perfect combination of extensive primary and secondary researches. The year 2017 is considered as the base year for forecasting further projections of the controlled substances market for the period between 2018 and 2028. 

Comprehensive telephonic interviews have been conducted for gaining first-hand, authoritative information on the controlled substances market’s current scenario and prospects. This information is then used for validating the insights gained from exhaustive secondary researches. 

This research methodology adopted for compiling the report on the controlled substances has enabled our analysts to deduce holistic insights into the controlled substances market’s growth prospects. This report serves as an authentic dataset for clients to further their business growth with precarious steps in their future business trajectory.

Research Methodology of this Report.

1. Executive Summary
     1.1. Global Market Outlook
     1.2. Demand Side Trends
     1.3. Supply Side Trends
     1.4. Technology Roadmap
     1.5. Analysis and Recommendations

2. Market Overview
     2.1. Market Coverage / Taxonomy
     2.2. Market Definition / Scope / Limitations

3. Key Market Trends
     3.1. Key Trends Impacting the Market, By Region
     3.2. Key Promotional Strategies, By Manufacturers

4. Key Success Factors
     4.1. Regulatory Scenario
     4.2. Drug Abuse Epidemiology
     4.3. Drug Abuse Statistics, U.S.
     4.4. Drug Abuse Statistics, European Union
     4.5. Pipeline Assessment
     4.6. Medical Marijuana Patent Filings
     4.7. Marijuana Statistics 
     4.8. Medical Marijuana Market Value Chain Analysis and Regulatory Scenario

5. Global Controlled Substances Market Demand (in Value or Size in US$ Mn) Analysis 2013-2017 and Forecast, 2018-2028
     5.1. Historical Market Value (US$ Mn) Analysis, 2013-2017
     5.2. Current and Future Market Value (US$ Mn) Projections, 2018-2028
            5.2.1. Y-o-Y Growth Trend Analysis
            5.2.2. Absolute $ Opportunity Analysis

6. Market Background
     6.1. Macro-Economic Factors
            6.1.1. Global GDP Growth Outlook
            6.1.2. Changing Government Policies 
            6.1.3. Reference Pricing
            6.1.4. Healthy economic growth in Emerging Countries 
            6.1.5. Rise In Global Annual Disposable Income Per Capita 
     6.2. Forecast Factors - Relevance & Impact
            6.2.1. Increasing Prevalence of Chronic Diseases
            6.2.2. Legalization of Marijuana And Reach of CS to Unmet Regions  
            6.2.3. Rising Controlled Substances Abuse
            6.2.4. Extensive Network of Distribution Channels
            6.2.5. Production Volume for Raw Materials, Like Opium and Marijuana  
     6.3. Market Dynamics
            6.3.1. Drivers
            6.3.2. Restraints
            6.3.3. Opportunity 

7. Global Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, by Drug Class 
     7.1. Introduction / Key Findings
     7.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013 - 2017
     7.3. Current Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2018 - 2028
            7.3.1. Opioids
                    7.3.1.1. Codeine
                    7.3.1.2. Morphine
                    7.3.1.3. Fentanyl
                    7.3.1.4. Meperidine
                    7.3.1.5. Methadone
                    7.3.1.6. Oxycodone
                    7.3.1.7. Others
            7.3.2. Stimulants
                    7.3.2.1. Amphetamine
                    7.3.2.2. Methylphenidate
                    7.3.2.3. Dextroamphetamine
                    7.3.2.4. Methamphetamine
                    7.3.2.5. Others
            7.3.3. Depressants
                    7.3.3.1. Barbiturates
                    7.3.3.2. Benzodiazepines
            7.3.4. Marijuana
                    7.3.4.1. Medical Marijuana
                    7.3.4.2. Recreational Marijuana
     7.4. Market Attractiveness Analysis By Drug Class 

8. Global Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, by Application
     8.1. Introduction / Key Findings
     8.2. Historical Market Size (US$ Mn) Analysis By Application, 2013 - 2017
     8.3. Current Market Size (US$ Mn)  Analysis and Forecast By Application, 2018 - 2028
            8.3.1. Attention-Deficit/Hyperactivity Disorder (ADHD)
            8.3.2. Pain Management
            8.3.3. Depression
            8.3.4. Seizure
            8.3.5. Anxiety            
            8.3.6. Sleep Disorders
            8.3.7. Cough Suppression
            8.3.8. Others
     8.4. Market Attractiveness Analysis By Application

9. Global Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, by Distribution Channel
     9.1. Introduction / Key Findings
     9.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013 - 2017
     9.3. Current Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2018 - 2028
            9.3.1. Institutional Sale
                    9.3.1.1. Hospitals
                    9.3.1.2. Clinics
                    9.3.1.3. Rehabilitation Centers
            9.3.2. Retail Sales
                    9.3.2.1. Retail Pharmacies
                    9.3.2.2. E- Commerce/Mail Order Pharmacies
     9.4.  Market Attractiveness Analysis By Distribution Channel

10. Global Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, by Region
     10.1. Introduction
     10.2. Historical Market Size (US$ Mn) Analysis By Region, 2013 - 2017
     10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2018 - 2018
            10.3.1. North America
            10.3.2. Latin America
            10.3.3. Europe
            10.3.4. Middle East and Africa (MEA)
            10.3.5. East Asia
            10.3.6. South Asia
            10.3.7. Oceania
     10.4. Market Attractiveness Analysis By Region

11. North America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028
     11.1. Introduction
     11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
     11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
            11.3.1.  By Country
                    11.3.1.1. U.S.
                    11.3.1.2. Canada
            11.3.2. By Drug Class
            11.3.3. By Application
            11.3.4. By Distribution Channel
     11.4. Market Attractiveness Analysis
            11.4.1. By Country
            11.4.2. By Drug Class
            11.4.3. By Application
            11.4.4. By Distribution Channel
     11.5. Drivers and Restraints - Impact Analysis

12. Latin America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028
     12.1. Introduction
     12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
     12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
            12.3.1. By Country
                    12.3.1.1. Brazil
                    12.3.1.2. Mexico
                    12.3.1.3. Rest of Latin America
            12.3.2. By Drug Class
            12.3.3. By Application
            12.3.4. By Distribution Channel
     12.4. Market Attractiveness Analysis
            12.4.1. By Country
            12.4.2. By Drug Class
            12.4.3. By Application
            12.4.4. By Distribution Channel
     12.5. Drivers and Restraints - Impact Analysis

13. Europe Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028
     13.1. Introduction
     13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
     13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
            13.3.1.  By Country
                    13.3.1.1. Germany
                    13.3.1.2. Italy
                    13.3.1.3. France
                    13.3.1.4. U.K.
                    13.3.1.5. Spain
                    13.3.1.6. BENELUX
                    13.3.1.7. Russia
                    13.3.1.8. Rest of Europe
            13.3.2. By Drug Class
            13.3.3. By Application
            13.3.4. By Distribution Channel
     13.4. Market Attractiveness Analysis
            13.4.1. By Country
            13.4.2. By Drug Class
            13.4.3. By Application
            13.4.4. By Distribution Channel
     13.5. Drivers and Restraints - Impact Analysis

14. South Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028
     14.1. Introduction
     14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
     14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
            14.3.1.  By Country
                    14.3.1.1. India
                    14.3.1.2. Thailand
                    14.3.1.3. Indonesia
                    14.3.1.4. Malaysia
                    14.3.1.5. Rest of South Asia
            14.3.2. By Drug Class
            14.3.3. By Application
            14.3.4. By Distribution Channel
     14.4. Market Attractiveness Analysis
            14.4.1. By Country
            14.4.2. By Drug Class
            14.4.3. By Application
            14.4.4. By Distribution Channel
     14.5. Drivers and Restraints - Impact Analysis

15. East Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028
     15.1. Introduction
     15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
     15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
            15.3.1.  By Country
                    15.3.1.1. China
                    15.3.1.2. Japan
                    15.3.1.3. South Korea
            15.3.2. By Drug Class
            15.3.3. By Application
            15.3.4. By Distribution Channel
     15.4. Market Attractiveness Analysis
            15.4.1. By Country
            15.4.2. By Drug Class
            15.4.3. By Application
            15.4.4. By Distribution Channel
     15.5. Drivers and Restraints - Impact Analysis

16. Oceania Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028
     16.1. Introduction
     16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
     16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2018 - 2028
            16.3.1.  By Country
                    16.3.1.1. Australia
                    16.3.1.2. New Zealand
            16.3.2. By Drug Class
            16.3.3. By Application
            16.3.4. By Distribution Channel
     16.4. Market Attractiveness Analysis
            16.4.1. By Country
            16.4.2. By Drug Class
            16.4.3. By Application
            16.4.4. By Distribution Channel
     16.5. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028
     17.1. Introduction
     17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2013 - 2017
     17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2018 - 2028
            17.3.1.  By Country
                    17.3.1.1. GCC Countries
                    17.3.1.2. Turkey
                    17.3.1.3. Northern Africa
                    17.3.1.4. South Africa
                    17.3.1.5. Rest of Middle East and Africa
            17.3.2. By Drug Class
            17.3.3. By Application
            17.3.4. By Distribution Channel
     17.4. Market Attractiveness Analysis
            17.4.1. By Country
            17.4.2. By Drug Class
            17.4.3. By Application
            17.4.4. By Distribution Channel
     17.5. Drivers and Restraints - Impact Analysis

18. Emerging Countries Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028
     18.1. Introduction
            18.1.1. Market Value Proportion Analysis, By Key Countries
            18.1.2. Global Vs. Country Growth Comparison
     18.2. South Africa Controlled Substances Market Analysis
            18.2.1. Introduction
            18.2.2. Market Value Proportion Analysis by Market Taxonomy
            18.2.3. Value (US$ Mn) Analysis and Forecast by Market Taxonomy
                    18.2.3.1. By Drug Class
                    18.2.3.2. By Distribution Channel
                    18.2.3.3. By Application
            18.2.4. South Africa Controlled Substances Market- Competition Landscape
     18.3. India Controlled Substances Market Analysis
            18.3.1. Introduction
            18.3.2. Market Value Proportion Analysis by Market Taxonomy
            18.3.3. Value (US$ Mn) Analysis and Forecast by Market Taxonomy
                    18.3.3.1. By Drug Class
                    18.3.3.2. By Distribution Channel
                    18.3.3.3. By Application
            18.3.4. India Controlled Substances Market- Competition Landscape
     18.4. Brazil Controlled Substances Market Analysis
            18.4.1. Introduction
            18.4.2. Market Value Proportion Analysis by Market Taxonomy
            18.4.3. Value (US$ Mn) Analysis and Forecast by Market Taxonomy
                    18.4.3.1. By Drug Class
                    18.4.3.2. By Distribution Channel
                    18.4.3.3. By Application
            18.4.4. Brazil Controlled Substances Market- Competition Landscape

19. Competition Analysis
     19.1. Competition Dashboard
     19.2. Competition Deep Dive 
            19.2.1. Cambrex
                    19.2.1.1. Overview
                    19.2.1.2. Product Portfolio
                    19.2.1.3. Profitability by Market Segments (Product/Channel/Region)
                    19.2.1.4. Strategy Overview
            19.2.2. Cambrex
            19.2.3. Patheon
            19.2.4. Consort Medical
            19.2.5. Cayman Chemical
            19.2.6. AMRI
            19.2.7. Siegfried AG            
            19.2.8. Johnson Matthey
            19.2.9. SAFC/Cerilliant
            19.2.10. Noramco, Inc
            19.2.11. Mallinckrodt plc
            19.2.12. GlaxoSmithKline plc.
            19.2.13. Purdue Pharma L.P.
            19.2.14. Teva Pharmaceuticals, Inc.
            19.2.15. Johnson & Johnson (Janssen)
            19.2.16. Daiichi Sankyo Company
            19.2.17. Akorn Inc
            19.2.18. Pfizer Inc.
            19.2.19. Takeda Pharmaceutical Company Limited
            19.2.20. Mylan N.V.
            19.2.21. Sun Pharmaceutical Industries Ltd
            19.2.22. Tilray
            19.2.23. GW PHARMACEUTICALS PLC
            19.2.24. Aphria Incorporation
            19.2.25. Aurora Cannabis Inc
            19.2.26. Canopy Growth Corporation
            19.2.27. Insys Therapeutics, Inc.
            19.2.28. Medical Marijuana, Inc.
            19.2.29. The Peace Naturals Project 
            19.2.30. CANNABIS SATIVA, INC.
            19.2.31. Green Relief Inc. 

20. Assumptions and Acronyms Used

21. Research Methodology

List Of Tables 

Table 01: Pipeline Assessment for Stimulants
Table 02: Expenditure on Health, (% of GDP), by Country, 2016–2021
Table 03: Expenditure on Health, (% of GDP), by Country, 2016–2021
Table 04: Global Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 05: Global Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 06: Global Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 07: Global Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 08: Global Controlled Substances Market size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2028 By Region
Table 09: North America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 10: North America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 11: North America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 12: North America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 13: North America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 14: Latin America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 15: Latin America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 16: Latin America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 17: Latin America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 18: Latin America Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 19: Europe Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 20: Europe Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 21: Europe Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 22: Europe Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 23: Europe Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 24: East Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 25: East Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 26: East Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 27: East Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 28: East Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 29: South Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 30: South Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 31: South Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 32: South Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 33: South Asia Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 34: Oceania Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 35: Oceania Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 36: Oceania Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 37: Oceania Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 38: Oceania Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 39: MEA Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Country
Table 40: MEA Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 41: MEA Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 42: MEA Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 43: MEA Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 44: Emerging Controlled Substances Market Value Proportion Analysis 2013-2017 and Forecast 2018-2028, By Country vs Global value
Table 45: India Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 46: India Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 47: India Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 48: India Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 49: South Africa Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 50: South Africa Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 51: South Africa Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 52: South Africa Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel
Table 53: Brazil Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 54: Brazil Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Drug Class
Table 55: Brazil Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Application
Table 56: Brazil Controlled Substances Market Analysis 2013-2017 and Forecast 2018-2028, By Distribution Channel

 

List of Figures

Figure 01: Pipeline Assessment For Opioids, By phase
Figure 02: Pipeline Assessment For Opioids, By Trial Status
Figure 03: Pipeline Assessment For Stimulants, By phase
Figure 04: Pipeline Assessment For Stimulants, By Trial Status
Figure 05: Medical Marijuana Patent Citations Analysis, 1998–2018, By Country
Figure 06: Medical Marijuana Patent Citations Analysis, from 2008–2018
Figure 07: Global Controlled Substances Market Value Analysis and Forecast, 2017–2028 (US$ Mn)
Figure 08: Global Controlled Substances Market Absolute $ Opportunity (US$ Mn), 2013–2017
Figure 09: Global Controlled Substances Market Absolute $ Opportunity (US$ Mn), 2017–2028
Figure 10: Global Controlled Substances Market Share%, by Drug Class, 2018E - Opioids
Figure 11: Global Controlled Substances Market Share%, by Drug Class, 2018E - Stimulants
Figure 12: Global Controlled Substances Market Share%, by Drug Class, 2018E - Depressants
Figure 13: Global Controlled Substances Market Share%, by Drug Class, 2018E - Marijuana
Figure 14: Global Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Opioids
Figure 15: Global Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Opioids
Figure 16: Global Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Stimulants
Figure 17: Global Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Stimulants
Figure 18: Global Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Depressants
Figure 19: Global Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Depressants
Figure 20: Global Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Marijuana
Figure 21: Global Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Marijuana
Figure 22: Global Controlled Substances Market Attractiveness Analysis, By Drug Class
Figure 23: Global Controlled Substances Market Attractiveness Analysis, By Application
Figure 24: Global Controlled Substances Market Attractiveness Analysis, By Distribution Channel
Figure 25: Global Controlled Substances Market Incremental Opportunity US$, by Region, 2018-2019
Figure 26: Controlled Substances Market Share%, by Region, 2018E
Figure 27: Global Controlled Substances Market Absolute Opportunity US$, by Region, 2018-2028
Figure 28: Controlled Substances Market Share%, by Region, 2028F
Figure 29: Global Controlled Substances Market Attractiveness Analysis, By Region
Figure 30: North America Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 31: North America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 32: US Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 33: US Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 34: Canada Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 35: Canada Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 36: North America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Opioids
Figure 37: North America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Opioids
Figure 38: North America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Stimulants
Figure 39: North America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Stimulants
Figure 40: North America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Depressants
Figure 41: North America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Depressants
Figure 42: North America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Marijuana
Figure 43: North America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Marijuana
Figure 44: North America Controlled Substances Market Attractiveness Analysis, By Drug Type
Figure 45: North America Controlled Substances Market Attractiveness Analysis, By Application
Figure 46: North America Controlled Substances Market Attractiveness Analysis, By Distribution Channel 
Figure 47: North America Controlled Substances Market Attractiveness Analysis, By Country
Figure 48: Latin America Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 49: Latin America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 50: Brazil Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 51: Brazil Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 52: Mexico Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 53: Mexico Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 54: Rest of Latin America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 55: Rest of Latin America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 56: Latin America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Opioids
Figure 57: Latin America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Opioids
Figure 58: Latin America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Stimulants
Figure 59: Latin America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Stimulants
Figure 60: Latin America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Depressants
Figure 61: Latin America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Depressants
Figure 62: Latin America Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Marijuana
Figure 63: Latin America Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Marijuana
Figure 64: Latin America Controlled Substances Market Attractiveness Analysis, By Drug Type
Figure 65: Latin America Controlled Substances Market Attractiveness Analysis, By Application
Figure 66: Latin America Controlled Substances Market Attractiveness Analysis, By Distribution Channel 
Figure 67: Latin America Controlled Substances Market Attractiveness Analysis, By Country
Figure 68: Europe Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 69: Europe Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 70: U.K. Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 71: U.K. Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 72: Germany Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 73: Germany Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 74: France Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 75: France Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 76: Italy Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 77: Italy Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 78: Spain Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 79: Spain Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 80: BENELUX Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 81: BENELUX Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 82: Russia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 83: Russia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 84: Rest of Europe Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 85: Rest of Europe Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 86: Europe Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Opioids
Figure 87: Europe Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Opioids
Figure 88: Europe Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Stimulants
Figure 89: Europe Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Stimulants
Figure 90: Europe Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Depressants
Figure 91: Europe Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Depressants
Figure 92: Europe Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Marijuana
Figure 93: Europe Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Marijuana
Figure 94: Europe Controlled Substances Market Attractiveness Analysis, By Drug Type
Figure 95: Europe Controlled Substances Market Attractiveness Analysis, By Application
Figure 96: Europe Controlled Substances Market Attractiveness Analysis, By Distribution Channel 
Figure 97: Europe Controlled Substances Market Attractiveness Analysis, By Country
Figure 98: East Asia Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 99: East Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 100: China Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 101: China Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 102: Japan Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 103: Japan Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 104: South Korea Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 105: South Korea Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 106: East Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Opioids
Figure 107: East Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Opioids
Figure 108: East Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Stimulants
Figure 109: East Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Stimulants
Figure 110: East Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Depressants
Figure 111: East Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Depressants
Figure 112: East Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Marijuana
Figure 113: East Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Marijuana
Figure 114: East Asia Controlled Substances Market Attractiveness Analysis, By Drug Type
Figure 115: East Asia Controlled Substances Market Attractiveness Analysis, By Application
Figure 116: East Asia Controlled Substances Market Attractiveness Analysis, By Distribution Channel 
Figure 117: East Asia Controlled Substances Market Attractiveness Analysis, By Country
Figure 118: South Asia Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 119: Global Donor Egg IVF Market Attractiveness Analysis by Region , 2018-2028
Figure 119: South Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 120: India Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 121: India Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 122: Thailand Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 123: Thailand Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 124: Indonesia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 125: Indonesia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 126: Malaysia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 127: Malaysia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 128: Rest of South Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 129: Rest of South Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 130: South Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Opioids
Figure 131: South Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Opioids
Figure 132: South Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Stimulants
Figure 133: South Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Stimulants
Figure 134: South Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Depressants
Figure 135: South Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Depressants
Figure 136: South Asia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Marijuana
Figure 137: South Asia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Marijuana
Figure 138: South Asia Controlled Substances Market Attractiveness Analysis, By Drug Type
Figure 139: South Asia Controlled Substances Market Attractiveness Analysis, By Application
Figure 140: South Asia Controlled Substances Market Attractiveness Analysis, By Distribution Channel 
Figure 141: South Asia Controlled Substances Market Attractiveness Analysis, By Country
Figure 142: Oceania Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 143: Oceania Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 144: Australia Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 145: Australia Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 146: New Zealand Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 147: New Zealand Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 148: Oceania Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Opioids
Figure 149: Oceania Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Opioids
Figure 150: Oceania Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Stimulants
Figure 151: Oceania Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Stimulants
Figure 152: Oceania Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Depressants
Figure 153: Oceania Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Depressants
Figure 154: Oceania Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Marijuana
Figure 155: Oceania Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Marijuana
Figure 156: Oceania Controlled Substances Market Attractiveness Analysis, By Drug Type
Figure 157: Oceania Controlled Substances Market Attractiveness Analysis, By Application
Figure 158: Oceania Controlled Substances Market Attractiveness Analysis, By Distribution Channel 
Figure 159: Oceania Controlled Substances Market Attractiveness Analysis, By Country
Figure 160: MEA Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 161: MEA Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 162: South Africa Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 163: South Africa Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 164: GCC Countries Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 165: GCC Countries Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 166: Rest of MEA Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 167: Rest of MEA Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017
Figure 168: MEA Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Opioids
Figure 169: MEA Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Opioids
Figure 170: MEA Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Stimulants
Figure 171: MEA Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Stimulants
Figure 172: MEA Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Depressants
Figure 173: MEA Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Depressants
Figure 174: MEA Controlled Substances Market Size (US$ Mn) Analysis, 2013–2017, by Marijuana
Figure 175: MEA Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028, by Marijuana
Figure 176: MEA Controlled Substances Market Attractiveness Analysis, By Drug Type
Figure 177: MEA Controlled Substances Market Attractiveness Analysis, By Application
Figure 178: MEA Controlled Substances Market Attractiveness Analysis, By Distribution Channel 
Figure 179: MEA Controlled Substances Market Attractiveness Analysis, By Country
Figure 180: Controlled Substances Market Value Proportion Analysis, By Key Countries, 2018E
Figure 181: Global Vs. Country, Y-O-Y Growth Comparison
Figure 182: India Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 183: India Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 184: India Controlled Substances Market Attractiveness Analysis, By Drug Class
Figure 185: India Controlled Substances Market Attractiveness Analysis, By Application
Figure 186: India Controlled Substances Market Attractiveness Analysis, By Distribution Channel
Figure 187: South Africa Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 188: South Africa Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 189: South Africa Controlled Substances Market Attractiveness Analysis, By Drug Class
Figure 190: South Africa Controlled Substances Market Attractiveness Analysis, By Application
Figure 191: South Africa Controlled Substances Market Attractiveness Analysis, By Distribution Channel
Figure 192: Brazil Controlled Substances Market size (US$ Mn) Analysis, 2013–2017
Figure 193: Brazil Controlled Substances Market Value (US$ Mn) & Y-o-Y Growth (%), 2018–2028
Figure 194: Brazil Controlled Substances Market Attractiveness Analysis, By Drug Class
Figure 195: Brazil Controlled Substances Market Attractiveness Analysis, By Application
Figure 196: Brazil Controlled Substances Market Attractiveness Analysis, By Distribution Channel

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Benefits of Becoming a Fact.MR Client

  • Access to our global market coverage
  • Periodic updates on your sector
  • Exclusive discounts and offers
  • Greater flexibility for customization
  • Quick-research assistance for ad-hoc needs
  • Access to credible insights Fact.MR analyst interactions
  • Access to Fact.MR tools and research to fuel strategy development